We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Ridge Diagnostics, Inc. and Ameritox Ltd. Enter Into Licensing Agreement for Depression Biomarker Blood Test

News   Apr 10, 2012

 
Ridge Diagnostics, Inc. and Ameritox Ltd. Enter Into Licensing Agreement for Depression Biomarker Blood Test
 
 
Advertisement
 

RELATED ARTICLES

Oropharyngeal Secretions May Help To Reduce False Negative COVID-19 Test Results

News

A new study published in the Journal of Dental Research demonstrates that testing of oropharyngeal secretions may reduce the number of false negative results from nasal swab testing of COVID-19 patients.

READ MORE

Blood Tests Can Help To Predict the Risk of Liver Cirrhosis

News

Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet.

READ MORE

Clinical-grade Wearables Offer Continuous Monitoring for COVID-19

News

Researchers have introduced a novel wearable device and set of data algorithms specifically tailored to catch early signs and symptoms and monitor the progression of COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE